Literature DB >> 19624103

One-pot synthesis of unsymmetrical N-heterocyclic carbene ligands from N-(2-iodoethyl)arylamine salts.

B A Bhanu Prasad1, Scott R Gilbertson.   

Abstract

An approach that provides symmetrical, unsymmetrical, and asymmetric N-heterocyclic carbene (NHC) ligands is reported. Reaction of iodoethanol with aniline provides N-(2-iodoethyl)arylamine salts that are then converted to the corresponding iodide. Reaction with aliphatic or aromatic amines followed by triethyl orthoformate was used to provide 26 different NHC ligands.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19624103     DOI: 10.1021/ol901189m

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  4 in total

1.  Prodrug strategy for PSMA-targeted delivery of TGX-221 to prostate cancer cells.

Authors:  Yunqi Zhao; Shaofeng Duan; Xing Zeng; Chunjing Liu; Neal M Davies; Benyi Li; M Laird Forrest
Journal:  Mol Pharm       Date:  2012-05-01       Impact factor: 4.939

2.  The Rational Design, Synthesis, and Antimicrobial Properties of Thiophene Derivatives That Inhibit Bacterial Histidine Kinases.

Authors:  Thibaut Boibessot; Christopher P Zschiedrich; Alexandre Lebeau; David Bénimèlis; Catherine Dunyach-Rémy; Jean-Philippe Lavigne; Hendrik Szurmant; Zohra Benfodda; Patrick Meffre
Journal:  J Med Chem       Date:  2016-09-26       Impact factor: 7.446

3.  Structure-activity relationship (SAR) study of ethyl 2-amino-6-(3,5-dimethoxyphenyl)-4-(2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (CXL017) and the potential of the lead against multidrug resistance in cancer treatment.

Authors:  Gopalakrishnan Aridoss; Bo Zhou; David L Hermanson; Nicholas P Bleeker; Chengguo Xing
Journal:  J Med Chem       Date:  2012-05-23       Impact factor: 7.446

4.  A facile synthetic route to benzimidazolium salts bearing bulky aromatic N-substituents.

Authors:  Gabriele Grieco; Olivier Blacque; Heinz Berke
Journal:  Beilstein J Org Chem       Date:  2015-09-17       Impact factor: 2.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.